Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457412 | PMC |
http://dx.doi.org/10.14744/AnatolJCardiol.2018.77535 | DOI Listing |
Aims: Contact force (CF)-sensing radiofrequency (RF) catheters with an ablation index have shown reproducible outcomes for the treatment of atrial fibrillation (AF) in large multicentre studies. A dual-energy (DE) focal CF catheter to deliver RF and unipolar/biphasic pulsed field ablation (PFA), integrated with a three-dimensional (3D) mapping system, can provide operators with additional flexibility. The SmartfIRE study assessed the safety and efficacy of this novel technology for the treatment of drug-refractory, symptomatic paroxysmal AF.
View Article and Find Full Text PDFCASE (Phila)
October 2019
Department of Cardiology, Texas Heart Institute, Houston, Texas.
• Cor triatriatum dexter (CTD) can complicate percutaneous atrial septal interventions. • Clinically silent () CTD is detectable by new echocardiography techniques. • Using these techniques could improve patient selection and guide interventions.
View Article and Find Full Text PDFJ Cardiovasc Electrophysiol
June 2019
Hôpitaux Universitaires de Genève, Geneva, Switzerland.
Introduction: Stroke is one of the most feared complications during catheter ablation of atrial fibrillation (AF). While symptomatic thromboembolic events are rare, magnetic resonance imaging (MRI) may identify asymptomatic (ie, silent) cerebral lesions (SCLs) following pulmonary vein isolation (PVI) procedures.
Methods And Results: The REDUCE-TE Pilot was a prospective multicenter, single-arm observational study investigating the incidence of SCL in patients with symptomatic paroxysmal AF undergoing PVI with a novel gold-tip, externally irrigated ablation catheter.
Anatol J Cardiol
February 2019
Department of Cardiology, Koşuyolu Kartal Heart Training and Research Hospital; İstanbul-Turkey.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!